Rapidly aging populations and rising cases of lifestyle-related diseases (LRDs), like diabetes and hypertension, are driving ...
The dramatic growth of a key federal drug discount program has fueled debate about whether it is helping low-income patients ...
Lifestyle-related diseases are rapidly increasing, particularly among the lower socioeconomic brackets of the society. To ...